Leaflet ZELMAC 6mg tablets
Indicated for: irritable bowel syndrome with constipation
Route of administration: oral
Substance: tegaserod (laxative)
ATC: A03AE02 (Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Serotonin receptor antagonists)
This medicine may change blood electrolyte levels.
Tegaserod is a partial 5-HT4 receptor agonist used for the treatment of irritable bowel syndrome with constipation (IBS-C) in women and chronic idiopathic constipation. It stimulates intestinal motility and increases fluid secretion in the intestine, thereby alleviating symptoms.
The medication is taken orally, usually twice daily before meals, as directed by a doctor. It is important for patients to follow the prescribed dosage and inform the doctor of any unusual symptoms.
Patients should be aware of potential side effects, such as abdominal pain, diarrhea, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include abdominal pain, diarrhea, nausea, and dizziness. In rare cases, severe reactions such as intestinal ischemia or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about ZELMAC 6mg
- Substance: tegaserod
- Date of latest medicines list: 01-07-2013
- Product code: W12737001
- Concentration: 6mg
- Pharmaceutical form: tablets
- Quantity: 30
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.